ASCO GI 2023 Conference Coverage
Playback speed
10 seconds
ASCO GI 2023 Debate: For a Fit Patient With Unresectable Metastatic RAS WT Sigmoid Colon Adenocarcinoma, 1L EGFR Antibody Is an Essential Treatment - CON
By
ASCO GI 2023 Conference Coverage
FEATURING
Ardaman Shergill
By
ASCO GI 2023 Conference Coverage
FEATURING
Ardaman Shergill
191 views
January 31, 2023
Login to view comments.
Click here to Login
Videos